JDM  Vol.5 No.4 , November 2015
Evaluation of BMI and Lipids Profile in Type 2 Diabetic Subjects with Low and Raised Levels of Thyroid Hormone in Calabar, Nigeria
Abstract: Relationship between lipid levels and BMI was investigated in euthyroid, hyperthyroid, hypothyroid, general Type 2 diabetics, and non-diabetic control subjects. FT4, T4, T3 and TSH did not differ in obese and non-obese diabetics but were higher in diabetics than in non-diabetics (p = 0.015, 0.012, 0.0164 respectively). Levels of FT4 correlated with TC, LDL-C, VLDL-C, TG and HDL-C (r = 0.179, p = 0.034; r = 0.183, p = 0.033; r = 0.183 p = 0,033; r = 0.176, p = 0.037; r = -0.210, p = 0.023 respectively). T3 levels correlated with TC (r = 0.210: p = 0.023), LDL-C (r = 0.193: p = 0.025), and VLDL-C (r = 0.244: p = 0.003) levels in diabetic subjects. FT4 and T4 levels correlated with BMI only in the non-diabetic subjects (p = 0.022, 0.025) respectively. TC and LDL-C levels correlated positively with BMI in non-diabetics (r = 0.265, p = 0.006; r = 0.249, p = 0.010), general diabetics (r = 0.247, p = 0.016; r = 0.291, p = 0.002), euthyroid (r = 0.274, p =0.017; r = 0.252, p = 0.022) and hyperthyroid (r = 0295, p = 0.008; r = 0.346, p = 0.002) diabetics respectively. There were negative correlations between BMI and HDL-C in the diabetics (r = -0.188, p = 0.018) and euthyroid (r = -0.273, p =0.018) groups. Atherogenic index correlated negatively with BMI in all 5 groups of subjects. The coexistence of both low and raised levels of thyroid hormones in the diabetic population altered the levels and interrelationship between lipids and BMI. Altered levels of FT4 observed in Type 2 diabetics emanated from diabetes not obesity. Atherogenic index is an efficient indicator of atherogenic risk irrespective of complications.
Cite this paper: Udiong, C. , Etukudoh, M. , Isong, I. and Udoisa, E. (2015) Evaluation of BMI and Lipids Profile in Type 2 Diabetic Subjects with Low and Raised Levels of Thyroid Hormone in Calabar, Nigeria. Journal of Diabetes Mellitus, 5, 277-283. doi: 10.4236/jdm.2015.54034.

[1]   Smithson, M.J. (1998) Screening for Thyroid Dysfunction in a Community of Diabetic Patients. Diabetics Medicinal, 15, 148-150.<148::AID-DIA540>3.0.CO;2-H

[2]   Radetti, G., Paganini, C., Gentili, L., Babin, F., Pasquino, B. and Zachinann, M. (1994) Altered Adrenal and Thyroid Function in Children with Insulin Dependent Diabetes Mellitus. Acta Diabetologia, 31, 128-140.

[3]   Tunbridge, W.M.G., Evered, D.C. and Hall, R. (1977) The Spectrum of Thyroid Diseases in a Community, the Wickhen Survey. Clinical Endocrinology, 7, 481-493.

[4]   Udiong, C.E.J., Udoh, A.E. and Etukudoh, H.E. (2007) Evaluation of Thyroid Function in Diabetes Mellitus in Calabar, Nigeria. Indian Journal of Clinical Biochemistry, 22, 74-78.

[5]   Celani, M.F., Bonati, M.E. and Stucci, N. (1994) Prevalence of Abnormal Thyrotropin Concentration Measured by a Sensitive Assay in Patients with Type 2 Diabetes Mellitus. Diabetes Research, 27, 15-25.

[6]   Udiong, C.E.J., Etukudoh, H.E. and Essien, O.E. (2007) Lipid Profile and Thyroid Hormones in Type 1 and Type 2 Diabetics. Journal of Medical Laboratory Science, 16, 59-67.

[7]   WHO (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complication. Report of WHO Part1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Department of Non Communicable Disease Surveillance, Geneva.

[8]   Trinder, P. (1969) Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor. Annals of Clinical Biochemistry, 6, 24-27.

[9]   Devi, M.A., Singh, N.S. and Singh, S.S. (2013) Thyroid Dysfunction in Type 2 Diabetic Patients in Urban Area of Minipur. International Journal of Pharmaceutical Invention, 2, 7-9.

[10]   Peros, P., McCrimmon, R.J., Shaw, G. and Frier, B.M. (1995) Frequency of Thyroid Dysfunction in Diabetic Patients; Value of Annual Screening. Diabetic Medicine, 12, 622-627.

[11]   Dias, C.M., Noqueirap, P., Rosa, A.V., de Sa, J.V., Gouvea, M.F. and Falcao, J.C.M. (1995) Total Cholesterol and High Density Lipoprotein Cholesterol in Patients with Non-Insulin Dependent Diabetes Mellitus. Acta M├ędica Portuguesa, 8, 619-628.

[12]   Nelson, D. (2012) Hypothyroidism and Obesity. Gastric

[13]   Pearce, E.N. (2012) Thyroid Hormone and Obesity. Current Opinion in Endocrinology Diabetes and Obesity, 19, 408-413.

[14]   Whitley, R.J. (1999) Thyroid Function. In: Burtis, C.A. and Ashwood, E.R., Eds., Text Book of Clinical Chemistry, 3rd Edition, W.B. Saunder Company, Philadelphia, 1496.

[15]   Bandursk-Stankiewicz, E. (2013) Thyroid Hormones Obesity and Metabolic Syndrome. Proceedings of the 4th Congress of Polish Thyroid Association, Lodz, 11-13 April 2013, A5.

[16]   Suzukki, J., Nannom, H., Gemma, R., Tanaka, I., Taminato, T. and Yoshimi, T. (1994) The Mechanism of Thyroid Hormone Abnormalities in Patients with Diabetes Mellitus. Folia Endocrinologica Japonica, 70, 465-470.

[17]   Strissower, E.H. (1971) Thyroid Status and Lipoprotein Pattern. In: Escamila, R.F., Ed., Laboratory Tests in Diagnosis and Investigation of Endocrine Function, 2nd Edition, F.A. Davis Company, Philadelphia, 101-111.

[18]   De Greef, W.J., Rondeel, J.M., Van-Hasteran, G.A., Klootwij, K.W. and Visser, T.J. (1992) Regulation of TRH Production and Release in Rats. Acta Medica Australia, 19, 77-79.

[19]   Hage, M., Zantout, M.S. and Azar, S.T. (2011) Thyroid Disorders and Diabetes Mellitus. Journal of Thyroid Research, 2011, 1-7.

[20]   Howard, B.V. (1987) Lipoprotein Metabolism in Diabetes Mellitus. Journal of Lipid Research, 28, 613-628.

[21]   Goldberg, I.J., Le, N.-A., Paternity, J.R., Ginsberg, H.N., Lindgren, F.T. and Brown, W.V. (1982) Lipoprotein Metabolism during Acute Inhibition of Hepatic Triglyceride Lipase in Nomolgus Monkey. Journal of Clinical Investigation, 70, 1184-1192.

[22]   Ginsberg, H.N. (1991) Lipoprotein Physiology in Non Diabetic and Diabetic States: Relationship to Atherogenesis. Diabetes Care, 14, 839-855.